Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 739 DKK 1.51%
Market Cap: 52.2B DKK
Have any thoughts about
Zealand Pharma A/S?
Write Note

Intrinsic Value

ZEAL's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ZEAL stock under the Base Case scenario is 201.52 DKK. Compared to the current market price of 739 DKK, Zealand Pharma A/S is Overvalued by 73%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ZEAL Intrinsic Value
201.52 DKK
Overvaluation 73%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Zealand Pharma A/S

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ZEAL
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ZEAL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ZEAL?
Bearish
Neutral
Bullish

Fundamental Analysis

739 DKK
+1.51%
+1.51%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Zealand Pharma A/S
DK
Biotechnology
Market Cap
52.2B DKK
IPO
Nov 1, 2010
Employees
355
Denmark
Market Cap
52.2B DKK
Industry
Biotechnology
IPO
Nov 1, 2010
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Zealand Pharma A/S

Provide an overview of the primary business activities
of Zealand Pharma A/S.

What unique competitive advantages
does Zealand Pharma A/S hold over its rivals?

What risks and challenges
does Zealand Pharma A/S face in the near future?

Summarize the latest earnings call
of Zealand Pharma A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zealand Pharma A/S.

Provide P/S
for Zealand Pharma A/S.

Provide P/E
for Zealand Pharma A/S.

Provide P/OCF
for Zealand Pharma A/S.

Provide P/FCFE
for Zealand Pharma A/S.

Provide P/B
for Zealand Pharma A/S.

Provide EV/S
for Zealand Pharma A/S.

Provide EV/GP
for Zealand Pharma A/S.

Provide EV/EBITDA
for Zealand Pharma A/S.

Provide EV/EBIT
for Zealand Pharma A/S.

Provide EV/OCF
for Zealand Pharma A/S.

Provide EV/FCFF
for Zealand Pharma A/S.

Provide EV/IC
for Zealand Pharma A/S.

Show me price targets
for Zealand Pharma A/S made by professional analysts.

What are the Revenue projections
for Zealand Pharma A/S?

How accurate were the past Revenue estimates
for Zealand Pharma A/S?

What are the Net Income projections
for Zealand Pharma A/S?

How accurate were the past Net Income estimates
for Zealand Pharma A/S?

What are the EPS projections
for Zealand Pharma A/S?

How accurate were the past EPS estimates
for Zealand Pharma A/S?

What are the EBIT projections
for Zealand Pharma A/S?

How accurate were the past EBIT estimates
for Zealand Pharma A/S?

Compare the revenue forecasts
for Zealand Pharma A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Zealand Pharma A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zealand Pharma A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zealand Pharma A/S compared to its peers.

Compare the P/E ratios
of Zealand Pharma A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Zealand Pharma A/S with its peers.

Analyze the financial leverage
of Zealand Pharma A/S compared to its main competitors.

Show all profitability ratios
for Zealand Pharma A/S.

Provide ROE
for Zealand Pharma A/S.

Provide ROA
for Zealand Pharma A/S.

Provide ROIC
for Zealand Pharma A/S.

Provide ROCE
for Zealand Pharma A/S.

Provide Gross Margin
for Zealand Pharma A/S.

Provide Operating Margin
for Zealand Pharma A/S.

Provide Net Margin
for Zealand Pharma A/S.

Provide FCF Margin
for Zealand Pharma A/S.

Show all solvency ratios
for Zealand Pharma A/S.

Provide D/E Ratio
for Zealand Pharma A/S.

Provide D/A Ratio
for Zealand Pharma A/S.

Provide Interest Coverage Ratio
for Zealand Pharma A/S.

Provide Altman Z-Score Ratio
for Zealand Pharma A/S.

Provide Quick Ratio
for Zealand Pharma A/S.

Provide Current Ratio
for Zealand Pharma A/S.

Provide Cash Ratio
for Zealand Pharma A/S.

What is the historical Revenue growth
over the last 5 years for Zealand Pharma A/S?

What is the historical Net Income growth
over the last 5 years for Zealand Pharma A/S?

What is the current Free Cash Flow
of Zealand Pharma A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zealand Pharma A/S.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zealand Pharma A/S

Current Assets 8.7B
Cash & Short-Term Investments 8.5B
Receivables 245.5m
Other Current Assets 803k
Non-Current Assets 911.4m
Long-Term Investments 746.1m
PP&E 128.9m
Intangibles 11.6m
Other Non-Current Assets 24.8m
Current Liabilities 245.6m
Accounts Payable 229.7m
Other Current Liabilities 15.9m
Non-Current Liabilities 501.1m
Long-Term Debt 373.6m
Other Non-Current Liabilities 127.5m
Efficiency

Earnings Waterfall
Zealand Pharma A/S

Revenue
76.9m DKK
Cost of Revenue
-21.5m DKK
Gross Profit
55.4m DKK
Operating Expenses
-1.2B DKK
Operating Income
-1.1B DKK
Other Expenses
73.9m DKK
Net Income
-1.1B DKK

Free Cash Flow Analysis
Zealand Pharma A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ZEAL Profitability Score
Profitability Due Diligence

Zealand Pharma A/S's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

26/100
Profitability
Score

Zealand Pharma A/S's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

ZEAL Solvency Score
Solvency Due Diligence

Zealand Pharma A/S's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Zealand Pharma A/S's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZEAL Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZEAL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZEAL is 1 008.94 DKK with a low forecast of 757.5 DKK and a high forecast of 1 155 DKK.

Lowest
Price Target
757.5 DKK
3% Upside
Average
Price Target
1 008.94 DKK
37% Upside
Highest
Price Target
1 155 DKK
56% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ZEAL?

Click here to dive deeper.

Dividends

Zealand Pharma A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for ZEAL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

ZEAL News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one ZEAL stock?

The intrinsic value of one ZEAL stock under the Base Case scenario is 201.52 DKK.

Is ZEAL stock undervalued or overvalued?

Compared to the current market price of 739 DKK, Zealand Pharma A/S is Overvalued by 73%.

Back to Top